Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 3:25 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 961–984 of 2,509 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Apoplexy Clear all

Conditions: Carotid Artery Disease, Carotid Artery Stenosis
Interventions: Carotid Artery Stenting; Device
Lead sponsor: W.L.Gore & Associates; Industry
Eligibility: 18 Years and older
Enrollment: 312 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2020
U.S. locations: 2
States / cities: Honolulu, Hawaii • Wynnewood, Pennsylvania

Conditions: Hypertension, Stroke
Interventions: Not listed
Lead sponsor: Columbia University; Other
Eligibility: 30 Years and older
Enrollment: 1,244 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2012
U.S. locations: 30
States / cities: Mobile, Alabama • Scottsdale, Arizona • Tucson, Arizona + 23 more

Conditions: Stroke
Interventions: IpsiHand Device; Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 88 Years
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Multiple Sclerosis, Stroke
Interventions: Movement to Music; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 65 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Stroke, Hemiparesis
Interventions: Split Belt treadmill; Behavioral
Lead sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; Other
Eligibility: 2 Years to 80 Years
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Stroke
Interventions: NeuroLife FES Sleeve / NeuroLife EMG-FES Sleeve; Device
Lead sponsor: Battelle Memorial Institute; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Cardiovascular Disease
Interventions: Febuxostat, Allopurinol; Drug
Lead sponsor: Takeda; Industry
Eligibility: 50 Years and older
Enrollment: 6,198 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2017
U.S. locations: 202
States / cities: Decatur, Georgia • Dunwoody, Georgia • Marietta, Georgia + 199 more

Conditions: Intracranial Hemorrhages, Atrial Fibrillation
Interventions: Edoxaban, Non-anticoagulant medical therapy; Drug · Other
Lead sponsor: Population Health Research Institute; Other
Eligibility: 45 Years and older
Enrollment: 948 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 10
States / cities: Elk Grove Village, Illinois • Lisle, Illinois • New Orleans, Louisiana + 7 more

Conditions: Stroke, Hemiparesis
Interventions: Cortical Stimulation and rehabilitation, Rehabilitation; Device · Other
Lead sponsor: Northstar Neuroscience; Industry
Eligibility: 21 Years and older
Enrollment: 174 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 21
States / cities: Tucson, Arizona • Los Angeles, California • San Francisco, California + 17 more

Conditions: Stroke, Spasticity, Muscle
Interventions: Conventional robotic continuous passive movement training, Visual Feedback, Haptic and Visual Feedback; Device
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 18 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: PFO, PFO - Patent Foramen Ovale, Cryptogenic Stroke, Patent Foramen Ovale, PFO-associated Stroke
Interventions: Recross P3 Occluder (P3O) System; Device
Lead sponsor: Recross Cardio, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 5
States / cities: Los Angeles, California • Gainsville, Florida • Boston, Massachusetts + 2 more

Conditions: Stroke, Patent Foramen Ovale
Interventions: AMPLATZER™ PFO Occluder; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 1,214 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2030
U.S. locations: 78
States / cities: Birmingham, Alabama • Huntsville, Alabama • Chandler, Arizona + 63 more

Conditions: Stroke
Interventions: Control, Hip Exoskeleton, Ankle Exoskeleton; Other · Device
Lead sponsor: Georgia Institute of Technology; Other
Eligibility: 18 Years to 85 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Myocardial Infarction, Hypertension, Stroke
Interventions: BP REACH Intervention; Behavioral
Lead sponsor: University of Southern California; Other
Eligibility: 35 Years and older
Enrollment: 546 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 4
States / cities: Downey, California • Los Angeles, California • Sylmar, California + 1 more

Conditions: Pediatrics, Muscle Spasticity, Cerebral Palsy, Stroke
Interventions: Botulinum Toxin Type A; Biological
Lead sponsor: Allergan; Industry
Eligibility: 2 Years to 17 Years
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2018
U.S. locations: 24
States / cities: Pasadena, California • Pomona, California • San Diego, California + 19 more

Conditions: Atherosclerotic Disease, Carotid
Interventions: Not listed
Lead sponsor: VPDiagnostics; Industry
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 15
States / cities: Phoenix, Arizona • Los Angeles, California • San Francisco, California + 10 more

Conditions: Atrial Fibrillation, Stroke
Interventions: Apixaban, aspirin; Drug
Lead sponsor: Population Health Research Institute; Other
Eligibility: 55 Years and older
Enrollment: 4,012 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2023
U.S. locations: 23
States / cities: Mesa, Arizona • Little Rock, Arkansas • Larkspur, California + 20 more

Conditions: Atrial Fibrillation, Stroke
Interventions: On-screen electronic alert; Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 798 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Myocardial Infarction (MI), Stroke
Interventions: Smartphone application Antshrike; Device
Lead sponsor: Stanford University; Other
Eligibility: 40 Years to 79 Years
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Stanford, California

Conditions: Ischemic Stroke, Cryptogenic, Ischemic Stroke, Embolic, Hemorrhagic Stroke, Embolic Stroke of Undetermined Source, Recurrent Ischemic Stroke
Interventions: Not listed
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 900 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Chronic Stroke
Interventions: motor learning based therapy, MyoPro, Home Exercise Program; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 89 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Atrial Fibrillation, Arrhythmia
Interventions: Not listed
Lead sponsor: Tulane University; Other
Eligibility: 20 Years to 80 Years · Female only
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Brain Tumor, Stroke, Acute, Brain Aneurysm, Intracranial Arteriovenous Malformations, Carotid Stenosis, Cavernous Sinus Thrombosis
Interventions: Transradial approach; Device
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Newark, New Jersey

Conditions: Sickle Cell Disease, Cerebral Stroke
Interventions: Carbon Dioxide; Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 6 Years to 70 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2032
U.S. locations: 1
States / cities: St Louis, Missouri

Search by objective public record fields.

The Gore SCAFFOLD Clinical Study

Levels of Inflammatory Markers in the Treatment of Stroke-An SPS3 Ancillary Study

Treatment of Chronic Stroke With IpsiHand

From Clinic to Community: An Information and Communication Technology (ICT) Home-Based Exercise Training System for Translating Clinical Findings

Locomotor Training for Neurological Disease

Functional Electrical Stimulation Therapy After Stroke

Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)

EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)

Safety and Effectiveness of Cortical Stimulation in the Treatment of Stroke Patients With Upper Extremity Hemiparesis

Robotic Interventions for Spasticity Treatment

Early Feasibility Study (EFS) Evaluating Percutaneous Repair of the Atrial Septum With a Novel PFO Occluder: The PROTEA-PFO Study

AMPLATZER PFO Occluder Post Approval Study

Clinical Efficacy of Exoskeleton Assistance for Individuals Post-Stroke

Reducing Blood Pressure in Patients With High Cardiovascular Risk

BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity

SmartRisk Stroke Prediction by MRI of Carotid Disease

Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation

Electronic Alerts for Stroke Prevention in Atrial Fibrillation

Smartphone Application to PREDICT Real-Time Cardiovascular Risk for Heart Attack and Stroke

Left Atrial Strain and Cryptogenic Stroke

Exoskeleton Research: Myoelectric Orthosis for Rehab of Severe Chronic Arm Motor Deficits

Epigenetic Analysis of Regulation of the Inflammasome-activating NLRP3 Gene in Monocytes From Atrial Fibrillation Patients and Controls

Safety and Feasibility of the Infinity Catheter for Radial Access

Cerebrovascular Reactivity Measurements With High-Density Diffuse Optical Tomography